Company / Cash per Share
Niagen Bioscience, Inc. Cash per Share History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.46
FY2021
5-year range
$0.46 / $0.46
FY2019-FY2021
Trend
+62.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $341.48 to $0.46 over the past 2 years.
Based on SEC 10-K filings.
0.46 in FY2021.
Declined from $341.48 to $0.46 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, cash per share increased 62.7% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.46 | +62.7% |
| FY2020 | $0.28 | -99.9% |
| FY2019 | $341.48 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026